Meta-regression of risk factors for microalbuminuria in type 2 diabetes

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 43, Issue 2, 2012, Pages 455-466

  Mongkolsomlit, Sirsima ^a   Patumanond, Jayanton ^a   Tawichasri, Chamaiporn ^a   Komoltri, Chulalux ^b   Rawdaree, Petch ^c  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Bangkok Metropolitan College of Medicine   (Thailand)

Author keywords

Meta regression; Microalbuminuria; Type 2 diabetes

Indexed keywords

EID: 84862564542     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Abdella NA, Mojiminiyi OA, Akanji AO, Moussa MA. Associations of plasma homocysteine in subjects with type 2 diabetes mellitus. Acta Diabetol 2002; 39: 183-90.
2. Aekplakorn W, Srivanichakorn S, Sangwatanaroj S. Microabluminuria and metabolic risk factors in patients with type 2 diabetes in primary care setting in Thailand. Diab Res Clin Prac 2009; 84: 92-98.
3. Ahmedani MY, Hydrie MZI, Iqbal A, Gul A, Mirza WB. Prevalence of microalbuminuria in type 2 diabetic patients in Karachi: Pakistan: a multi-center study. J Pak Med Assoc 2005; 55: 382-6.
4. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2009; 32: S13-61.
5. Amini M, Safaei H, Aminorroaya A. The incidence of microalbuminuria and its associated risk factors in type 2 diabetic patients in Isfahan, Iran. Rev Diabetic Stud 2007; 4: 242-8.
6. Bakris GL, Slataper R, Vicknair N, Sadler R. ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects. J Diabetes Complications 1994; 8: 2-6.
7. Bakris GL, Smith AC, Richardson DJ, et al. Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study. J Hum Hypertens 2002; 16: 185-91.
8. Baris N, Erdogan M, Sezer E, et al. Alterations in L-arginine and inflammatory markers in type 2 diabetic patients with and without microalbuminuria. Acta Diabetol 2009; 46: 309-16.
9. Baykan M, Erdogan T, Erem C, et al. The relationship between flow-mediated dilatation and lift ventricular in type 2 diabetic patients with microalbuminuria. Endocrine 2006; 30: 197-202.
10. Behan KJ, Mbizo J. The relationship between waist circumference and biomarkers for diabetes and CVD in healthy non-obese women. The Pensacola Study. Lab Med 2007; 38: 422-27.
11. Bennett PH. 'Microalbuminuria' and diabetes: a critique-assessment of urinary albumin excretion and its role in screening for diabetic nephropathy. Am J Kidney Dis 1989; 13: 29-34.
12. Bonnet F, Cooper ME. Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies. Diabet Med 2000; 26: 254-64.
13. Bruno G, Merletti F, Biggeri A, et al. Progression to overt nephropathy in type 2 diabetes. Diabetes Care 2003; 26: 2150-5.
14. Buranakitjaroen P, Deerochanawong C, Bunnag P. Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand. J Med Assoc Thai 2005; 88: 1624-29.
15. Cagliego E, Roth T, Roy S, Orenzi M. Characteristics and mechanism of high glucose induced over expression of basement membrance components in cultured human endothelial cells. Diabetes 1991; 40: 102-12.
16. Cederholm J, Eliasson B, Nilsson PM, Weiss L, Gudbjornsdottir S. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diab Res Clin Prac 2005; 67: 258-66.
17. Egger M, Devey Smith G, Stettler C, Diem P. Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med 1997; 14: 919-28.
18. Esteghamati A, Khalilzadeh O, Anvari M, et al. Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity. Metab Syndr Relat Disord 2009; 7: 447-52.
19. Friedman AN, Hunsicker LG, Selhub J, Bostom AG. Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy. Atherosclerosis 2004; 172: 121-5.
20. Golan L, Birkmeyer JD, Welch HG. The costeffectiveness of treating all patients with Type 2 diabetes with angiotensin-converting enzyme inhibitors. Ann Intern Med 1999; 131: 660-7.
21. Hashim R, Rehman K-U, Ahmed TA, et al. Microalbuminuria and associated risk factors in type 2 diabetics. J Coll Physicial Surg Pak 2004; 14: 84-7.
22. Helaly MA, Sheashaa HA, Hatata ESZ, et al. Endothelial dysfunction in geriatric diabetic patients: the role of microalbuminuria in elderly type 2 diabetic patients? A randomized controlled study. Int Urol Nephrol 2007; 39: 333-8.
23. International Diabetes Federation resourses page. The IDF consensus worldwide definition of the metabolic syndrome. [Cited 2010 Mar 15]. Available from: URL: http://www.idf.org/webdata/docs/MetS_def_update2006.pdf
24. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17: 1-12.
25. Lutale JJK, Thordarson H, Abbas ZG, Vetvik K. Microalbuminuria among type 1 and type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania. BMC Nephrol 2007; 8(2). [Cited 2008 Feb 8]. Available from URL: http://www.biomedcentral.com/1471-2369/8/2. doi:10.1186/1471-2369- 8-2.
26. Matsui J, Tamasawa N, Tanabe J, et al. LDL particle size and lipid composition are risk factors for microalbuminuria in normotensive and normocholesterolemic patients with type 2 diabetes. Diab Res Clin Prac 2004; 66: 229-36.
27. Mattock MB, Barnes DJ, Viberti G, et al. Microalbuminuria and coronary heart disease in NIDDM: an incidence study. Diabetes 1998; 47: 1786-92.
28. Mattock MB, Morrish NJ, Viberti G, et al. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 41: 736-41.
29. Messent JWC, Elliott TG, Hill RD, et al. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 1992; 41: 836-9.
30. Modebe O, Masoomi MA. Microalbuminuria and associated factors in Bahraini patients with type 2 diabetes mellitus. Ann Saudi Med 2000; 20: 157-60.
31. Mongkolsomlit S, Rawdaree P. Factors affecting microalbuminuria in type 2 diabetes: metaanalysis. Srinagarind Med J 2010; 25: 185-93.
32. Piarulli F, Sartore G, Ceriello A, et al. Relationship between glyco-oxidation, antioxidant status and microalbuminuria in type 2 diabetic patients. Diabetologia 2009; 52: 1419-25.
33. Poulsen PL. ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria. J Renin Angiotensin Aldosterone Syst 2003; 4: 17-26.
34. Ritz E. Albuminuria and vascular damage-the vicious twins. N Engl J Med 2003; 348: 2349-52.
35. Rossi MC, Nicolucci A, Pellegrini F, et al. Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) study. Nephrol Dial Transplant 2008; 23: 1278-84.
36. Schmitz A, Vaeth M, Mogensen C. Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM. Diabetologia 1994; 37: 1251-8.
37. Shoji T, Emoto M, Kawagishi T, et al. Atherogenic lipoprotein changes in diabetic nephropathy. Atherosclerosis 2001; 156: 425-33.
38. Stroup D, Berlin J, Morton S, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
39. Turner R, Holman R, Stratton I, et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-13.
40. Unnikrishnan R, Rema M, Pradeepa R, Deepa M. Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: The Chennai Urban Rural Epidemiology Study (CURES 45). Diabetes Care 2007; 30: 2019-24.
41. Varghese A, Deepa R, Rema M, Mohan V. Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India. Postgrad Med J 2001; 77: 399-402.
42. Wu AYT, Kong NCT, de Leon FA, et al. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the microalbuminuira prevalence (MAP) study. Diabetologia 2005; 48: 17-26.
43. Yerong Y, Lixia S, Hongling Y, Chun W, Hong T. Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria. Diab Res Clin Prac 2004; 65: 95-104.
44. Yokoyama H, Kawai K, Kobayashi M. Microalbuminuria is common in Japanese type 2 diabetic patients:A nationwide survey from the Japan Diabetes Clinical Data Management Study Group (JDDM 10). Diabetes Care 2007; 30: 989-92.